A role for androgens in regulating circadian behavior and the suprachiasmatic nucleus.
The suprachiasmatic nucleus (SCN) of the hypothalamus is the locus of a master circadian clock controlling behavioral and physiological rhythms, including rhythmic secretion of gonadal hormones. Gonadectomy results in marked alteration of circadian behaviors, including lengthened free-running period, decreased precision of daily onset of running, and elimination of early-evening but not late-night activity bouts. Androgen replacement restores these responses. These aspects of rhythmicity are thought to be regulated by the brain clock, although the site of androgen action remains unknown. Anatomically, the rodent SCN is composed of a ventrolateral core and a dorsomedial shell, and the present studies show that androgen receptors (AR) are localized to the ventrolateral core SCN. Using a transgenic mouse bearing dual reporter molecules driven by the AR targeted to both membrane and nucleus, we find that projections of AR-containing cells form a dense plexus in the core, with their fibers appearing to exit the SCN dorsally. In a second transgenic strain, in which the retinorecipient gastrin-releasing peptide cells express a green fluorescent protein reporter, we show that gastrin-releasing peptide cells contain AR. Through immunocytochemistry, we also show that SCN AR cells express FOS after a light pulse. Importantly, gonadectomy reduces the FOS response after a phase-shifting light pulse, whereas androgen replacement restores levels to those in intact animals. Taken together, the results support previous findings of a hypothalamic neuroendocrine feedback loop. As such, the SCN regulates circadian rhythms in gonadal hormone secretion, and in turn, androgens act on their receptors within the SCN to alter circadian function.
Karatsoreos
Ilia N
IN
Department of Psychology, Columbia University, New York, NY 10027, USA.
Wang
Alice
A
Sasanian
Jasmine
J
Silver
Rae
R
D000728:Androgens / Q000502:physiology*; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002452:Cell Count; D002940:Circadian Rhythm / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D013196:Dihydrotestosterone / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008954:Models, Biological; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D009919:Orchiectomy; D011944:Receptors, Androgen / Q000235:genetics / Q000378:metabolism; D013493:Suprachiasmatic Nucleus / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D013739:Testosterone / Q000494:pharmacology
D000728:Androgens; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D013739:Testosterone
J Neurosci. 2003 Sep 3;23(22):8070-6
12954869
Mol Endocrinol. 2003 Sep;17(9):1738-50
12791770
Endocrine. 1999 Oct;11(2):137-43
10709760
Science. 2000 Apr 28;288(5466):682-5
10784453
Acta Ophthalmol Scand. 2000 Apr;78(2):146-53
10794246
J Comp Neurol. 2000 Sep 25;425(3):422-35
10972942
J Comp Neurol. 2004 Jan 12;468(3):361-79
14681931
J Neurosci. 2004 Jan 7;24(1):68-75
14715939
Biol Rev Camb Philos Soc. 2004 Feb;79(1):61-77
15005173
Neurosci Biobehav Rev. 2004 Mar;28(1):55-63
15036933
J Neurochem. 2004 Aug;90(4):769-75
15287881
Neuron. 2004 Aug 5;43(3):313-9
15294140
Proc Natl Acad Sci U S A. 1975 Sep;72(9):3744-7
1059163
Q Rev Biol. 1979 Sep;54(3):265-99
390600
Am J Physiol. 1980 Jan;238(1):R97-101
7356053
Physiol Behav. 1981 May;26(5):825-38
7267776
J Comp Neurol. 1982 Apr 10;206(3):273-7
7085933
Am J Physiol. 1983 Jan;244(1):R93-105
6849422
Sleep. 1984;7(1):27-51
6718923
Experientia. 1984 Nov 15;40(11):1226-34
6500007
Physiol Behav. 1985 Dec;35(6):985-92
4095192
Physiol Behav. 1990 Sep;48(3):403-8
2267249
Biol Reprod. 1990 Oct;43(4):586-91
2289012
Endocrinology. 1994 Jun;134(6):2622-7
8194487
Neuron. 1995 Apr;14(4):697-706
7718233
Brain Res Dev Brain Res. 1995 Feb 16;84(2):278-81
7743647
J Comp Neurol. 1996 Dec 23;376(4):567-86
8978471
Prog Brain Res. 1996;111:103-19
8990910
J Biol Rhythms. 1997 Apr;12(2):122-35
9090566
Endocrinology. 1998 Apr;139(4):1594-601
9528939
Endocrinology. 1998 Oct;139(10):4092-101
9751487
Brain Res. 1999 Feb 20;819(1-2):23-32
10082857
J Neuroendocrinol. 1999 Jul;11(7):481-90
10444305
Curr Biol. 2004 Dec 29;14(24):R1038-9
15620633
Trends Neurosci. 2005 Mar;28(3):145-51
15749168
Nat Neurosci. 2005 Apr;8(4):476-83
15750589
Mol Cell Endocrinol. 2005 May 31;236(1-2):1-7
15876478
Nat Rev Genet. 2005 Jul;6(7):544-56
15951747
J Neurochem. 2005 Sep;94(6):1639-51
16011741
J Neurosci. 2005 Nov 30;25(48):11155-64
16319315
Nature. 2005 Dec 22;438(7071):1095-6
16371996
Eur J Neurosci. 2006 Feb;23(4):1047-53
16519669
J Biol Rhythms. 2006 Dec;21(6):458-69
17107936
J Biol Rhythms. 2007 Feb;22(1):3-13
17229920
Curr Biol. 2007 Mar 6;17(5):468-73
17320387
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7664-9
17463091
J Biol Rhythms. 2001 Apr;16(2):105-16
11302553
Eur J Neurosci. 2001 Aug;14(4):666-74
11556891
J Neurosci. 2001 Oct 1;21(19):7742-50
11567064
Brain Res. 2001 Oct 19;916(1-2):172-91
11597605
Mol Pharmacol. 2002 Jan;61(1):26-34
11752203
Ann N Y Acad Sci. 2001 Dec;949:44-57
11795379
Eur J Neurosci. 2002 Apr;15(7):1153-62
11982626
Neuroreport. 2002 May 7;13(6):857-60
11997701
Eur J Neurosci. 2002 Oct;16(8):1531-40
12405967
Endocrinology. 2003 Jan;144(1):230-9
12488349
Eur J Neurosci. 2002 Dec;16(12):2469-74
12492442
Endocrinology. 2003 May;144(5):2055-67
12697714
Chronobiol Int. 2003 Mar;20(2):209-21
12723881
Science. 2003 Nov 21;302(5649):1408-12
14631044